Prestige Q2 fiscal 2022 revenue record $276.2M; raises full-year guidance

Prestige Consumer Healthcare Inc.

2022-Q2 EPS reported $2.03 revenue$545,406,000

Record Q2 revenue $276.2M (+16.3% YoY); organic growth 10.5% ex-Akorn and FX.
Adjusted diluted EPS $1.02, up 30.8% YoY; GAAP diluted EPS $0.89.
Raising FY2022 outlook: revenue $1.05-$1.06B (prior $1.045B+); adj. EPS $3.93-$3.98 (prior $3.90+).
North American OTC segment $251.7M (+16.2%); International OTC $24.5M (+17.5%).
Adjusted free cash flow $61.9M in Q2; net debt ~$1.6B with leverage 4.1x.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.